Aspira Pathlab & Diagnostics Limited
BSE: ASPIRA
Prev Close
62.3
Open Price
59.19
Volume
534
Today Low / High
59.19 / 64
52 WK Low / High
56.81 / 106.78
Range
61 - 67
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 63.9, reflecting a change of 1.6 (2.56822%). The expected target range on the BSE is 61 - 67. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Aspira Pathlab & Diagnostics Limited Graph
Aspira Pathlab & Diagnostics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aspira Pathlab & Diagnostics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 63.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 63.90 | 64.54 | 58.09 - 70.99 |
| 65.18 | 52.14 - 78.21 | ||
| 65.82 | 46.07 - 85.56 | ||
| Bearish Scenario | 63.90 | 63.26 | 56.93 - 69.59 |
| 62.62 | 50.10 - 75.15 | ||
| 61.98 | 43.39 - 80.58 |
Overview of Aspira Pathlab & Diagnostics Limited
ISIN
INE500C01017
Industry
Medical - Care Facilities
Vol.Avg
3,113
Market Cap
657,722,700
Last Dividend
0
Official Website
IPO Date
DCF Diff
25.19
DCF
39
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 13.20 Cr | 3.39 Cr | 9.81 Cr | 0.7432 | 0.00 Cr | 1.59 Cr | -2.70 Cr | -2.67 Cr | -2.60 | -0.77 Cr | -0.2024 |
| 2023-03-31 | 14.46 Cr | 3.07 Cr | 11.39 Cr | 0.7877 | 0.00 Cr | 1.37 Cr | 0.01 Cr | -0.09 Cr | -0.09 | 1.91 Cr | -0.0061 |
| 2022-03-31 | 19.54 Cr | 4.50 Cr | 15.04 Cr | 0.7695 | 0.00 Cr | 1.05 Cr | 4.74 Cr | 4.46 Cr | 4.33 | 6.47 Cr | 0.2282 |
| 2021-03-31 | 15.21 Cr | 4.85 Cr | 10.36 Cr | 0.6812 | 0.00 Cr | 1.00 Cr | 2.07 Cr | 1.38 Cr | 1.45 | 3.72 Cr | 0.0908 |
| 2020-03-31 | 8.42 Cr | 2.37 Cr | 6.05 Cr | 0.7184 | 0.00 Cr | 0.73 Cr | -3.49 Cr | -4.24 Cr | -4.95 | -1.54 Cr | -0.5038 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 0.80 Cr | 14.71 Cr | 4.57 Cr | 10.1433 Cr | 2.78 Cr | 1.98 Cr | 0.45 Cr | 4.12 Cr | 0.00 Cr | 0.00 Cr | 2.99 Cr | 2.0710 Cr |
| 2023-03-31 | 0.57 Cr | 17.34 Cr | 4.59 Cr | 12.7504 Cr | 2.35 Cr | 1.79 Cr | 0.40 Cr | 5.31 Cr | 0.00 Cr | 0.00 Cr | 3.13 Cr | 1.5848 Cr |
| 2022-03-31 | 1.35 Cr | 18.14 Cr | 5.35 Cr | 12.7894 Cr | 3.06 Cr | 1.71 Cr | 0.40 Cr | 6.82 Cr | 0.01 Cr | 0.00 Cr | 1.08 Cr | 1.7887 Cr |
| 2021-03-31 | 1.18 Cr | 11.78 Cr | 3.46 Cr | 8.3145 Cr | 1.32 Cr | 0.13 Cr | 0.37 Cr | 4.96 Cr | 0.02 Cr | 0.00 Cr | 0.14 Cr | 2.0112 Cr |
| 2020-03-31 | 0.09 Cr | 14.34 Cr | 10.53 Cr | 3.8009 Cr | 8.19 Cr | 8.10 Cr | 0.28 Cr | 6.04 Cr | 0.01 Cr | 0.00 Cr | 2.35 Cr | 5.1214 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1.0530 Cr | 0.1383 Cr | -0.9541 Cr | 0.7898 Cr | 0.2372 Cr | 0.8038 Cr | -0.2619 Cr | -2.6722 Cr | 0.1154 Cr | 0.0000 Cr | -0.0483 Cr |
| 2023-03-31 | -0.0121 Cr | 0.1593 Cr | -0.9350 Cr | -0.1484 Cr | -0.7878 Cr | 0.5666 Cr | -0.1363 Cr | -0.0887 Cr | 0.1030 Cr | 0.0000 Cr | 0.0056 Cr |
| 2022-03-31 | 2.0310 Cr | -0.5123 Cr | -1.3520 Cr | 1.4240 Cr | 0.1667 Cr | 1.3544 Cr | -0.6070 Cr | 4.4594 Cr | -0.4955 Cr | 0.0000 Cr | -0.0378 Cr |
| 2021-03-31 | 5.6734 Cr | -0.0919 Cr | -2.1720 Cr | 5.3777 Cr | 3.4094 Cr | 1.1877 Cr | -0.2957 Cr | 1.3810 Cr | -3.7849 Cr | 0.0000 Cr | -0.0902 Cr |
| 2020-03-31 | -1.8671 Cr | 0.2406 Cr | 1.2733 Cr | -1.9145 Cr | -0.3532 Cr | -2.2217 Cr | -0.0474 Cr | -4.2406 Cr | -0.2320 Cr | 0.0000 Cr | 0.0036 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 5.41 Cr | 1.07 Cr | 4.33 Cr | 0.8016 | 0.38 Cr | 0.31 Cr | 0.30 | 0.79 Cr | 0.0566 |
| 2024-09-30 | 6.18 Cr | 1.36 Cr | 4.82 Cr | 0.7801 | 0.99 Cr | 0.99 Cr | 0.96 | 1.43 Cr | 0.1602 |
| 2024-06-30 | 4.64 Cr | 3.18 Cr | 1.46 Cr | 0.3144 | -0.03 Cr | 0.05 Cr | 0.05 | 0.50 Cr | 0.0102 |
| 2024-03-31 | 3.82 Cr | 2.94 Cr | 0.88 Cr | 0.2293 | -0.49 Cr | -0.50 Cr | -0.49 | -0.04 Cr | -0.1316 |
| 2023-12-31 | 3.46 Cr | 2.94 Cr | 0.52 Cr | 0.1507 | -0.75 Cr | -0.74 Cr | -0.72 | -0.27 Cr | -0.2143 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.03 Cr | 0.39 Cr | 2.42 Cr | 0.00 Cr | 0.56 Cr | 5.87 Cr | 3.49 Cr | 15.82 Cr | 4.64 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 1.38 Cr | 0.00 Cr | 0.00 Cr | 1.38 Cr | 0.00 Cr | 0.00 Cr | -10.14 Cr |
| 2024-03-31 | 1.38 Cr | 0.59 Cr | 1.38 Cr | 2.24 Cr | 0.45 Cr | 4.36 Cr | 4.12 Cr | 14.71 Cr | 4.57 Cr |
| 2023-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.47 Cr | 1.62 Cr | 2.09 Cr | 1.97 Cr | 0.46 Cr | 5.07 Cr | 5.81 Cr | 16.03 Cr | 4.70 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.00 Cr | 0.76 Cr | 0.00 Cr | 0.00 Cr | 0.76 Cr | 2.88 Cr | 2.12 Cr | 0.00 Cr | 0.76 Cr |
| 2023-09-30 | -0.71 Cr | -0.71 Cr | 0.00 Cr | 0.00 Cr | -0.71 Cr | 2.12 Cr | 2.83 Cr | 0.00 Cr | -0.71 Cr |
| 2023-06-30 | 0.00 Cr | -0.72 Cr | 0.00 Cr | 0.00 Cr | -1.28 Cr | -0.72 Cr | 0.57 Cr | 0.00 Cr | -0.72 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,123.20 | ₹1,091,909,894,400.00 | ₹1,287,137.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹6,725.00 | ₹966,954,125,000.00 | ₹305,783.00 |
| Fortis Healthcare Limited | FORTIS | ₹663.00 | ₹500,537,154,000.00 | ₹634,759.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,772.50 | ₹362,229,872,500.00 | ₹203,729.00 |
| Global Health Limited | MEDANTA | ₹1,168.00 | ₹313,710,048,160.00 | ₹124,896.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹529.10 | ₹264,292,328,300.00 | ₹421,311.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹632.95 | ₹253,267,980,050.00 | ₹264,711.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,340.20 | ₹136,099,553,495.00 | ₹246,543.00 |
| HealthCare Global Enterprises Limited | HCG | ₹548.50 | ₹76,469,127,500.00 | ₹272,253.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹376.10 | ₹34,478,215,300.00 | ₹111,880.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹238.00 | ₹33,058,200,000.00 | ₹49,503.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1990
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born:
FAQs about Aspira Pathlab & Diagnostics Limited
The CEO is Dr. Pankaj Jashwant Shah.
The current price is ₹63.90.
The range is ₹56.81-106.78.
The market capitalization is ₹65.77 crores.
The P/E ratio is 77.58.
The company operates in the Healthcare sector.
Overview of Aspira Pathlab & Diagnostics Limited (ISIN: INE500C01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹65.77 crores and an average daily volume of 3,113 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.